Experienced in Dermatomyositis

Dr. Angela D. Hawkes

Rheumatology
2835 Horse Pen Creek Rd, Suite 101, 
Greensboro, NC 
Accepting New Patients
Offers Telehealth
Experienced in Dermatomyositis
2835 Horse Pen Creek Rd, Suite 101, 
Greensboro, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Angela Hawkes is a Rheumatologist in Greensboro, North Carolina. Dr. Hawkes is rated as an Experienced provider by MediFind in the treatment of Dermatomyositis. Her top areas of expertise are Rheumatoid Arthritis (RA), Psoriatic Arthritis, Psoriasis, and Sjogren Syndrome. Dr. Hawkes is currently accepting new patients.

Her clinical research consists of participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in NC
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

GREENSBORO RHEUMATOLOGY PA
2835 Horse Pen Creek Rd, Suite 101, Greensboro, NC 27410

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
Enrollment Status: Completed
Publish Date: November 07, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Drug: Olokizumab
Study Phase: Phase 3
View 3 Less Clinical Trials
Similar Doctors
Lisa G. Criscione-Schreiber
Distinguished in Dermatomyositis
Dr. Lisa G. Criscione-Schreiber
Rheumatology
Distinguished in Dermatomyositis
Dr. Lisa G. Criscione-Schreiber
Rheumatology

Duke Lupus Clinic - Clinic 1J

40 Duke Medicine Cir, 
Durham, NC 
 (53.8 miles away)
919-668-7630
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

I enjoy the long-term relationships I build with patients as a rheumatologist. My primary areas of clinical expertise in rheumatology are systemic lupus erythematosus (SLE, lupus) and inflammatory myopathies, especially dermatomyositis and the antisynthetase syndrome. I co-founded the Duke Lupus Clinic in 2007. I am also a passionate educator and mentor. I have led the Duke Rheumatology Fellowship Program to train rheumatology doctors since 2008. I chair the Department of Medicine Faculty Development Academy to mentor education scholars, and I serve as the Vice Chair for Education for the Duke Department of Medicine. In this role, I oversee educational programs throughout the Department of Medicine. When not working, I enjoy spending time with my husband and two children, exercising, and gardening. Dr. Criscione-Schreiber is rated as an Advanced provider by MediFind in the treatment of Dermatomyositis. Her top areas of expertise are Systemic Lupus Erythematosus (SLE), Dermatomyositis, Lupus Nephritis, and Rheumatoid Arthritis (RA).

Advanced in Dermatomyositis
Dr. Astia R. Allenzara
Rheumatology
Advanced in Dermatomyositis
Dr. Astia R. Allenzara
Rheumatology

University Of North Carolina At Chapel Hill

101 Manning Dr, 
Chapel Hill, NC 
 (49.2 miles away)
984-974-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Astia Allenzara is a Rheumatologist in Chapel Hill, North Carolina. Dr. Allenzara is rated as an Advanced provider by MediFind in the treatment of Dermatomyositis. Her top areas of expertise are Dermatomyositis, Polymyositis, Myositis, and Arthritis. Dr. Allenzara is currently accepting new patients.

Advanced in Dermatomyositis
Dr. Alfredo C. Rivadeneira
Rheumatology
Advanced in Dermatomyositis
Dr. Alfredo C. Rivadeneira
Rheumatology

University Of North Carolina At Chapel Hill

100 Eastowne Dr, 
Chapel Hill, NC 
 (50.7 miles away)
984-215-5556
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Alfredo Rivadeneira is a Rheumatologist in Chapel Hill, North Carolina. Dr. Rivadeneira is rated as an Advanced provider by MediFind in the treatment of Dermatomyositis. His top areas of expertise are Necrotizing Vasculitis, Behcet Disease, Takayasu Arteritis, and Rheumatoid Arthritis (RA). Dr. Rivadeneira is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hawkes's expertise for a condition
ConditionClose
    View All 25 Advanced Conditions
    View All 25 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile